Skip to content

A clinical study to evaluate the effect of an Ayurvedic nutraceutical supplement Nasaamrutam combined with nasal oil drops Anu Taila and Shirishavaleha in patients with Allergic Rhinitis.

Evaluation of the add-on effect of a traditional nutraceutical supplement Nasaamrutam with Anu Taila Pratimarsha Nasya and Shirishavaleha orally in the management of Vataja Pratishyaya (Allergic rhinitis) - An open-label double-arm randomized controlled clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099912
Enrollment
64
Registered
2025-12-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

None listed

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Presence of Kshavathu (sneezing) as a mandatory symptom. 2.Patients having 3 or more diagnostic symptoms (either intermittent or persistent pattern) of Vataja Pratishyaya,i.e., i.Nasasrava (rhinorrhea) ii.Nasauparodha (nasal blockage) iii.Mukhashosha (dry mouth) iv.Shirashoola (headache) v.Nasa bhru kandu (itchy nose eyebrow) - for a minimum of one year immediately preceding the study- Screening Visit

Exclusion criteria

Exclusion criteria: 1.Patients having lower respiratory tract infection. 2.Upper respiratory tract complaints such as nasal polyposis, nasal tumors, CSF rhinorrhea. 3.Patients with adenotonsillar hypertrophy, craniofacial syndromes, or neuromuscular diseases. 4.Patients with history of nasal surgery. 5.Other respiratory infectious conditions such as tuberculosis, pleural effusion, emphysema, lung abscess, bronchiectasis, pneumonia, pleurisy,etc. 6.Congenital anomalies of respiratory tract or rhinitis due to trauma. 7.Patients suffering from chronic debilitating diseases like HIV, Hepatitis-B, immuno- compromised patients etc. 8.Patients suffering from systemic diseases such as hypertension , diabetes mellitus etc. 9.Patients not willing to participate in the study.

Design outcomes

Primary

MeasureTime frame
Improvement in Kshavathu (sneezing) in Vataja Pratishyaya - Allergic Rhinitis.Timepoint: Day 0 (Baseline evaluation), 15th day, 30th day, 60th day (Follow- up)

Secondary

MeasureTime frame
Improvement in other symptoms of Vataja Pratishyaya -Allergic Rhinitis viz., Nasavarodha (Nasal obstruction), Kandu (Itching), Kasa (Cough), Shirahshul/ Shirogaurav (Headache), Gandhagyan (Loss of smell), Swarbheda (Hoarseness of voice).Timepoint: Day 0 (Baseline evaluation), 15th day, 30th day, 60th day (Follow- up);Decrease in the AEC ( cells/microlitre of blood) and serum IgE levels (IU/mL)Timepoint: Day 0 (Baseline evaluation), 15th day, 30th day, 60th day (Follow- up)

Countries

India

Contacts

Public ContactDr Aastha Agrawal

All India Institute of Ayurveda

bhatrajma2008@gmail.com9560788850

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026